RR
Rajeev Ranjan
About Rajeev Ranjan
Data last updated:
Rajeev Ranjan is a Director at Novotra Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals. Novotra Pharmaceuticals Private Limited reported revenue of ₹28.8 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novotra Pharmaceuticals Private Limited U24230PN2021PTC207257 | Director | 26 Feb 2024 | 2021 | ₹28.8 Lakh (FY 2023) | Active |
Board colleagues of Rajeev Ranjan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rakesh Kumar Baranwal | 09531334 | Novotra Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Ranjan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Ranjan
Rajeev Ranjan currently holds 1 directorship: Novotra Pharmaceuticals Private Limited (Director, since 26 Feb 2024, revenue ₹28.8 Lakh (FY 2023)).
Rajeev Ranjan was first appointed on 26 Feb 2024 as Director at Novotra Pharmaceuticals Private Limited.
The current boards of Rajeev Ranjan's companies include Rakesh Kumar Baranwal (Novotra Pharmaceuticals Private Limited).